Literature DB >> 9117322

Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland.

H Leverstein1, J E van der Wal, R M Tiwari, I van der Waal, G B Snow.   

Abstract

BACKGROUND: Recent modifications of surgical technique may have influenced outcome following parotidectomy. This retrospective study compares the results of the different surgical methods with regard to recurrence rate and the effects on morbidity between 1974 and 1994.
METHODS: A total of 246 primary surgical parotid procedures were performed on 245 patients for pleomorphic adenoma. These included 131 'partial' superficial parotidectomies, 61 'total' superficial parotidectomies, 30 partial superficial/deep lobe parotidectomies, eight total parotidectomies, and 16 'selective' deep lobe parotidectomies. In the recent past, the posterior branch of the greater auricular nerve was preserved in the majority of patients. Eleven patients received postoperative radiotherapy. Median follow-up was 95 months. Fourteen patients died without recurrent tumour.
RESULTS: Two patients (0.8 per cent) developed local recurrence, both after total parotidectomy for a deep lobe tumour. No patient experienced permanent facial nerve palsy. The incidence of gustatory sweating for partial superficial parotidectomy was 6.9 per cent (nine of 131) compared with 13.1 per cent (eight of 61) for total superficial parotidectomy.
CONCLUSION: Partial parotidectomy is an effective treatment for the majority of pleomorphic adenomas; local recurrence is rare and morbidity is low. Prolonged follow-up is unnecessary.

Entities:  

Mesh:

Year:  1997        PMID: 9117322

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  PAROTOID TUMOURS: A STUDY OF 65 CASES.

Authors:  L S Vohra; Ashok Kumar; G Rajagopal; H G Mukhopadhyay
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Classification of parotidectomies: a proposal of the European Salivary Gland Society.

Authors:  M Quer; O Guntinas-Lichius; F Marchal; V Vander Poorten; D Chevalier; X León; D Eisele; P Dulguerov
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-10       Impact factor: 2.503

Review 3.  Surgical options in benign parotid tumors: a proposal for classification.

Authors:  Miquel Quer; Vincent Vander Poorten; Robert P Takes; Carl E Silver; Carsten C Boedeker; Remco de Bree; Alessandra Rinaldo; Alvaro Sanabria; Ashok R Shaha; Albert Pujol; Peter Zbären; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-21       Impact factor: 2.503

4.  Benign parotid tumours.

Authors:  Mark McGurk
Journal:  BMJ       Date:  2004-12-04

5.  Recurrent pleomorphic adenoma.

Authors:  Rachel L Werner; James T Castle
Journal:  Head Neck Pathol       Date:  2013-11-07

6.  Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases.

Authors:  B D Hancock
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

7.  Identification of facial nerve during parotidectomy: a combined anatomical & surgical study.

Authors:  Somnath Saha; Sudipta Pal; Moushumi Sengupta; Kanishka Chowdhury; Vedula Padmini Saha; Lopamudra Mondal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-07-24

8.  Morbidity of parotid gland surgery: results 1 year post-operative.

Authors:  J Alexander de Ru; Peter Paul G van Benthem; Gerrit Jan Hordijk
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-28       Impact factor: 2.503

9.  Frey Syndrome, First Bite Syndrome, great auricular nerve morbidity, and quality of life following parotidectomy.

Authors:  Giacomo Fiacchini; Niccolò Cerchiai; Domenico Tricò; Stefano Sellari-Franceschini; Augusto Pietro Casani; Iacopo Dallan; Veronica Seccia
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-26       Impact factor: 2.503

10.  Long-term effects of parotidectomy.

Authors:  Bektaş Veli Kaya; Caner Kılıç; Samet Özlügedik; Ümit Tuncel; Ela Cömert
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.